Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of oral AND017 for beta-thalassemia
CTR20241128Phase 2Active
- Sponsor
- Ando Pharma
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AND017 in beta thalassemia, sponsored by Ando Pharma. Started Aug 2024; status: active.
02
Drugs
AND017
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on CTR20241128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241128.